PROVIDER PROFILE · NPI 1881807469

Joseph MerolaM.D., M.M.SC.

PRACTICEBRIGHAM AND WOMEN'S HOSPITALSee all providers at this practice →

DermatologyDallas, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

167

Unique beneficiaries

—

Total services

210

Distinct HCPCS

Medicare payment

$14K

Peer benchmark

Total Medicare services vs. 965 Dermatology providers in TX — bottom quintile (cohort median 2,537).

PRESCRIBING · PART D · 2024

Total Rx claims

190

Beneficiaries

—

Total drug cost

$508K

Distinct drugs

Brand share

51.6%

Top prescribed drugs

Clobetasol Propionate38 claims

Ixekizumab25 claims

Valacyclovir Hcl22 claims

Ketoconazole21 claims

Dupilumab20 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$142K

Payment records

221

By payment type

Consulting Fee$96K

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$34K

Travel and Lodging$9K

Food and Beverage$3K

REFERRAL NETWORK

Where Joseph Merola's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Alvaro Laga Canales Pathology · Boston, MA	13	24
THE GENERAL HOSPITAL CORPORATION	12	49
Victor Huang Dermatology · Sacramento, CA	12	47

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history